Literature DB >> 15502147

Familial amyloid polyneuropathy: hypertrophy of ligaments supporting the spinal cord.

Mika Kitajima1, Yukunori Korogi, Masayuki Yamura, Ichiro Ikushima, Yoshiko Hayashida, Yukio Ando, Makoto Uchino, Yasuyuki Yamashita.   

Abstract

We describe characteristic spinal MR findings of two cases of familial amyloid polyneuropathy (FAP). Both cases showed leptomeningeal enhancement on contrast-enhanced T1-weighted image. In addition, three-dimensional constructive interference in steady-state imaging demonstrated thickening of the ligaments, other connective tissues within the spinal canal, dura matter, and dorsal nerve roots. These findings in FAP are felt to represent amyloid deposition. Copyright American Society of Neuroradiology

Entities:  

Mesh:

Year:  2004        PMID: 15502147      PMCID: PMC7976396     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Evaluation of syringomyelia with three-dimensional constructive interference in a steady state (CISS) sequence.

Authors:  T Hirai; Y Korogi; Y Shigematsu; T Sugahara; M Takahashi; Y Ushio; S Uemura
Journal:  J Magn Reson Imaging       Date:  2000-02       Impact factor: 4.813

2.  Postmortem findings in primary familial amyloidosis with polyneuropathy.

Authors:  P A Hofer; R Anderson
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-05

3.  MR of leptomeningeal spinal and posterior fossa amyloid.

Authors:  S Horowitz; C Thomas; G Gruener; S Nand; J F Shea
Journal:  AJNR Am J Neuroradiol       Date:  1998-05       Impact factor: 3.825

4.  Presence of autoantibody against ATTR Val30Met after sequential liver transplantation.

Authors:  Yukio Ando; Hisayasu Terazaki; Katsuki Haraoka; Takahiro Tajiri; Masaaki Nakamura; Konen Obayashi; Shogo Misumi; Shozo Shoji; Kanako Hata; Kazuko Nakagawa; Takashi Ishizaki; Shinji Uemoto; Yukihiro Inomata; Koichi Tanaka; Hiroaki Okabe
Journal:  Transplantation       Date:  2002-03-15       Impact factor: 4.939

5.  Primary amyloidoma of the brain: CT and MR presentation.

Authors:  J Lee; G Krol; M Rosenblum
Journal:  AJNR Am J Neuroradiol       Date:  1995-04       Impact factor: 3.825

Review 6.  Transthyretin and familial amyloidotic polyneuropathy.

Authors:  Y Ando; S Araki; M Ando
Journal:  Intern Med       Date:  1993-12       Impact factor: 1.271

7.  Amyloid protein of vessels in leptomeninges, cortices, choroid plexuses, and pituitary glands from patients with systemic amyloidosis.

Authors:  T Ishihara; T Nagasawa; T Yokota; T Gondo; M Takahashi; F Uchino
Journal:  Hum Pathol       Date:  1989-09       Impact factor: 3.466

8.  Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene.

Authors:  M K Herrick; K DeBruyne; D S Horoupian; J Skare; M A Vanefsky; T Ong
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

9.  Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy.

Authors:  M Ushiyama; S Ikeda; N Yanagisawa
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study.

Authors:  K Takahashi; S Yi; Y Kimura; S Araki
Journal:  Hum Pathol       Date:  1991-06       Impact factor: 3.466

  10 in total
  3 in total

1.  Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration.

Authors:  Toshinori Hirai; Yukio Ando; Masayuki Yamura; Mika Kitajima; Yoshiko Hayashida; Yukunori Korogi; Taro Yamashita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

Review 2.  Imaging of focal amyloid depositions in the head, neck, and spine: amyloidoma.

Authors:  Hemant Parmar; T Rath; M Castillo; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

Review 3.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.